Magseed® tumor marker receives EU approval for implantation in soft tissue

The Magseed® marker, developed by Endomag (London, UK), has recently received European approval for long-term implantation in soft tissues. The tool is intended to mark suspicious lymph nodes as early in treatment as possible so that accurate removal of breast tumors in surgery is more feasible.Thanks to the rapid improvement of treatment options for those with breast cancer, chemotherapy is now often administered to patients before surgery has been explored. Unfortunately, this can often make it difficult to determine if the cancer has spread beyond the breast, so complete surgical removal of the tumor becomes more uncertain. The Magseed® marker...